| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024592 |
| Receipt No. | R000028303 |
| Official scientific title of the study | A preliminary genome-wide association study of plasma catechin concentration in Japanese individuals after ingestion of green tea catechins |
| Date of disclosure of the study information | 2016/10/27 |
| Last modified on | 2016/10/27 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A preliminary genome-wide association study of plasma catechin concentration in Japanese individuals after ingestion of green tea catechins | |
| Title of the study (Brief title) | A preliminary GWAS of plasma catechin concentration in Japanese individuals after ingestion of green tea catechins | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Japanese adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to investigate the causes of individual differences in plasma catechin concentrations by using a preliminary genome-wide association study of green tea catechin concentration in the plasma after ingestion. First, we examine the plasma catechin concentrations in healthy Japanese individuals. The subjects ingested 1 g of green tea catechins in a fasting state, and their plasma catechin concentration are measured 1 h after ingestion. The subjects are defined in terms of their plasma catechin concentration as follows: hyper-responders and hypo-responders. Second, we conduct a preliminary genome-wide association study of common variants associated with plasma catechin concentration 1 h after ingestion in those responders. |
| Basic objectives2 | Others |
| Basic objectives -Others | SNPs associated with plasma catechin concentration after 1 hour ingestion of catechins. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | SNPs associated with plasma catechin concentration after 1 hour ingestion of catechins |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Single oral dose of 1 g of green tea catechins in a fasting state | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Subjects are competent to consent, keep the rules of the study.
2) We measure plasma catechin concentration in subjects 1 h after ingestion of catechins. The subjects are defined in terms of their plasma catechin concentration as follows: hyper-responders (plasma catechin concentration is more than upper flexion point) and hypo-responders (plasma catechin concentration is less than lower flexion point). |
|||
| Key exclusion criteria | 1) Anemia
2) Subjects who are inadequate for enrollment judged by the investigator. |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Yuko Sagesaka, PhD |
| Organization | ITO EN, Ltd. |
| Division name | Central Research Institute |
| Address | 21 Mekami, Makinohara-shi, Shizuoka 421-0516, Japan |
| TEL | 0548-54-1247 |
| y-sagesaka@itoen.co.jp | |
| Public contact | |
| Name of contact person | Makoto Kobayashi, PhD |
| Organization | ITO EN, Ltd. |
| Division name | Central Research Institute |
| Address | 21 Mekami, Makinohara-shi, Shizuoka 421-0516, Japan |
| TEL | 0548-54-1247 |
| Homepage URL | |
| m-kobayasi@itoen.co.jp | |
| Sponsor | |
| Institute | Central Research Institute, ITO EN, Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Genequest Inc. |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | (株)伊藤園中央研究所(静岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028303 |